Skip to main navigation Skip to search Skip to main content

Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma

  • Jennifer M. Kwan
  • , Natalija Odanovic
  • , Amit Arbune
  • , Angela Higgins
  • , Mariana Henry
  • , Daniel Greif
  • , Francine Foss
  • , Lauren A. Baldassarre

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

A 62-year-old woman with human T-lymphotropic virus type 1 cell lymphoma developed heart failure after mogamulizumab, an immunotherapy agent. Clinical presentation and cardiac magnetic resonance imaging were consistent with myocarditis, and a recurrence of heart failure occurred after rechallenge with the therapy. (Level of Difficulty: Advanced.)

Original languageEnglish
Pages (from-to)1018-1023
Number of pages6
JournalJACC: Case Reports
Volume3
Issue number7
DOIs
StatePublished - Jul 7 2021

Bibliographical note

Publisher Copyright:
© 2021 The Authors

Funding

This work was supported by American Heart Association (grant #18CDA34110361; LAB, 2018). The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

FundersFunder number
American the American Heart Association18CDA34110361

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • MR sequences
    • acute heart failure
    • cancer
    • cardiomyopathy

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Fingerprint

    Dive into the research topics of 'Mogamulizumab-Associated Acute Myocarditis in a Patient With T-Cell Lymphoma'. Together they form a unique fingerprint.

    Cite this